172 related articles for article (PubMed ID: 9536032)
1. Pharmacological characterization of the human ionotropic glutamate receptor subtype GluR3 stably expressed in mammalian cells.
Varney MA; Rao SP; Jachec C; Deal C; Hess SD; Daggett LP; Lin F; Johnson EC; Veliçelebi G
J Pharmacol Exp Ther; 1998 Apr; 285(1):358-70. PubMed ID: 9536032
[TBL] [Abstract][Full Text] [Related]
2. Cyclothiazide and AMPA receptor desensitization: analyses from studies of AMPA-induced release of [3H]-noradrenaline from hippocampal slices.
Cowen MS; Beart PM
Br J Pharmacol; 1998 Feb; 123(3):473-80. PubMed ID: 9504388
[TBL] [Abstract][Full Text] [Related]
3. Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: lack of competition between cyclothiazide and GYKI 52466.
Kessler M; Arai A; Quan A; Lynch G
Mol Pharmacol; 1996 Jan; 49(1):123-31. PubMed ID: 8569697
[TBL] [Abstract][Full Text] [Related]
4. Regulation of SULT2B1a (pregnenolone sulfotransferase) expression in rat C6 glioma cells: relevance of AMPA receptor-mediated NO signaling.
Kohjitani A; Fuda H; Hanyu O; Strott CA
Neurosci Lett; 2008 Jan; 430(1):75-80. PubMed ID: 18054434
[TBL] [Abstract][Full Text] [Related]
5. Cyclothiazide decreases [3H]AMPA binding to rat brain membranes: evidence that AMPA receptor desensitization increases agonist affinity.
Hall RA; Kessler M; Quan A; Ambros-Ingerson J; Lynch G
Brain Res; 1993 Nov; 628(1-2):345-8. PubMed ID: 7508813
[TBL] [Abstract][Full Text] [Related]
6. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
Johansen TH; Chaudhary A; Verdoorn TA
Mol Pharmacol; 1995 Nov; 48(5):946-55. PubMed ID: 7476926
[TBL] [Abstract][Full Text] [Related]
7. Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists.
Desai MA; Burnett JP; Ornstein PL; Schoepp DD
J Pharmacol Exp Ther; 1995 Jan; 272(1):38-43. PubMed ID: 7529311
[TBL] [Abstract][Full Text] [Related]
8. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
Nielsen EO; Varming T; Mathiesen C; Jensen LH; Moller A; Gouliaev AH; Wätjen F; Drejer J
J Pharmacol Exp Ther; 1999 Jun; 289(3):1492-501. PubMed ID: 10336544
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization, localization, and regulation of ionotropic glutamate receptors in skate horizontal cells.
Kreitzer MA; Birnbaum AD; Qian H; Malchow RP
Vis Neurosci; 2009; 26(4):375-87. PubMed ID: 19678977
[TBL] [Abstract][Full Text] [Related]
10. Stable expression of recombinant AMPA receptor subunits: binding affinities and effects of allosteric modulators.
Hennegriff M; Arai A; Kessler M; Vanderklish P; Mutneja MS; Rogers G; Neve RL; Lynch G
J Neurochem; 1997 Jun; 68(6):2424-34. PubMed ID: 9166736
[TBL] [Abstract][Full Text] [Related]
11. 5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: novel, systemically active and broad spectrum antagonists for NMDA/glycine, AMPA, and kainate receptors.
Cai SX; Huang JC; Espitia SA; Tran M; Ilyin VI; Hawkinson JE; Woodward RM; Weber E; Keana JF
J Med Chem; 1997 Oct; 40(22):3679-86. PubMed ID: 9357535
[TBL] [Abstract][Full Text] [Related]
12. AMPA (amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptors in human brain tissues.
Sawutz DG; Krafte DS; Oleynek JJ; Ault B
J Recept Signal Transduct Res; 1995 Jul; 15(6):829-46. PubMed ID: 7584514
[TBL] [Abstract][Full Text] [Related]
13. Presynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-mediated stimulation of glutamate and GABA release in the rat striatum in vivo: a dual-label microdialysis study.
Patel DR; Young AM; Croucher MJ
Neuroscience; 2001; 102(1):101-11. PubMed ID: 11226673
[TBL] [Abstract][Full Text] [Related]
14. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
15. Evidence that functional glutamate receptors are not expressed on rat or human cerebromicrovascular endothelial cells.
Morley P; Small DL; Murray CL; Mealing GA; Poulter MO; Durkin JP; Stanimirovic DB
J Cereb Blood Flow Metab; 1998 Apr; 18(4):396-406. PubMed ID: 9538905
[TBL] [Abstract][Full Text] [Related]
16. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.
Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G
Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974
[TBL] [Abstract][Full Text] [Related]
17. Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants.
Partin KM; Patneau DK; Mayer ML
Mol Pharmacol; 1994 Jul; 46(1):129-38. PubMed ID: 8058047
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological detection of AMPA receptor heterogeneity by use of two allosteric potentiators in rat hippocampal cultures.
Sekiguchi M; Takeo J; Harada T; Morimoto T; Kudo Y; Yamashita S; Kohsaka S; Wada K
Br J Pharmacol; 1998 Apr; 123(7):1294-303. PubMed ID: 9579722
[TBL] [Abstract][Full Text] [Related]
19. [3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain.
Wright RA; Arnold MB; Wheeler WJ; Ornstein PL; Schoepp DD
J Pharmacol Exp Ther; 2001 Aug; 298(2):453-60. PubMed ID: 11454905
[TBL] [Abstract][Full Text] [Related]
20. The glutamate receptor/NO/cyclic GMP pathway in the hippocampus of freely moving rats: modulation by cyclothiazide, interaction with GABA and the behavioural consequences.
Fedele E; Conti A; Raiteri M
Neuropharmacology; 1997 Oct; 36(10):1393-403. PubMed ID: 9423927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
